HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong Yu Selected Research

Inflammation (Inflammations)

12/2023Berberine ameliorate inflammation and apoptosis via modulating PI3K/AKT/NFκB and MAPK pathway on dry eye.
12/2022Resveratrol activates the SIRT1/PGC-1 pathway in mice to improve synaptic-related cognitive impairment after TBI.
1/2022Regulation of wound healing and fibrosis by galectins.
1/2022Novel approach by natural language processing for COVID-19 knowledge discovery.
2/2015The role of selenoprotein W in inflammatory injury in chicken immune tissues and cultured splenic lymphocyte.
6/2012[Myocardial injury and inflammatory response after interventional therapy in children with congenital heart disease].
1/2004Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma.
11/2003A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong Yu Research Topics

Disease

38Neoplasms (Cancer)
03/2024 - 04/2002
28Infections
01/2024 - 09/2006
8Inflammation (Inflammations)
12/2023 - 11/2003
7Virus Diseases (Viral Diseases)
01/2022 - 03/2010
6Wounds and Injuries (Trauma)
01/2024 - 11/2008
5Body Weight (Weight, Body)
01/2022 - 11/2004
4Glioblastoma (Glioblastoma Multiforme)
03/2024 - 05/2003
4Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 02/2016
4Hypoxia (Hypoxemia)
06/2022 - 11/2007
4Neoplasm Metastasis (Metastasis)
01/2021 - 01/2012
4Hypersensitivity (Allergy)
10/2015 - 09/2002
3Glioma (Gliomas)
03/2024 - 01/2021
3Hepatocellular Carcinoma (Hepatoma)
12/2023 - 09/2022
3Hemorrhage
12/2023 - 01/2019
3Ischemia
12/2023 - 01/2015
3Colonic Neoplasms (Colon Cancer)
01/2023 - 04/2002
3Cognitive Dysfunction
12/2022 - 01/2022
3Lung Neoplasms (Lung Cancer)
01/2022 - 07/2002
3Cicatrix (Scar)
01/2022 - 10/2017
3Breast Neoplasms (Breast Cancer)
01/2020 - 05/2003
3Congenital Abnormalities (Deformity)
11/2008 - 03/2006
3Asthma (Bronchial Asthma)
09/2007 - 09/2002
2Stomach Neoplasms (Stomach Cancer)
03/2024 - 01/2023
2Intervertebral Disc Degeneration
01/2024 - 10/2020
2Bacterial Infections (Bacterial Infection)
01/2024 - 09/2023
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 01/2023
2Liver Neoplasms (Liver Cancer)
12/2023 - 09/2019
2Psoriasis (Pustulosis Palmaris et Plantaris)
12/2023 - 07/2013
2Hyperglycemia
01/2023 - 01/2023
2Proteinuria
01/2023 - 11/2013
2Fibrosis (Cirrhosis)
09/2022 - 01/2022
2Dyslipidemias (Dyslipidemia)
06/2022 - 01/2022
2Emerging Communicable Diseases (Emerging Infectious Diseases)
01/2022 - 10/2019
2Communicable Diseases (Infectious Diseases)
01/2022 - 10/2019
2Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 01/2022
2Myocardial Ischemia (Ischemic Heart Diseases)
12/2021 - 07/2018
2Prostatic Neoplasms (Prostate Cancer)
01/2020 - 02/2003
2Atrial Fibrillation
01/2019 - 01/2019
2Pain (Aches)
05/2018 - 02/2010
2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2009 - 09/2009
1Metaplasia
03/2024

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
03/2024 - 02/2003
8RNA (Ribonucleic Acid)IBA
01/2024 - 01/2017
8OligonucleotidesIBA
09/2007 - 04/2002
7VaccinesIBA
01/2022 - 09/2002
7Antisense OligonucleotidesIBA
09/2006 - 04/2002
6Therapeutic UsesIBA
01/2024 - 04/2002
6Indicators and Reagents (Reagents)IBA
01/2024 - 02/2015
6DNA (Deoxyribonucleic Acid)IBA
10/2017 - 04/2004
6Viral DNAIBA
01/2014 - 09/2006
5Messenger RNA (mRNA)IBA
06/2022 - 09/2006
4Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2003
3ResveratrolIBA
03/2024 - 01/2022
3Sirtuin 1IBA
03/2024 - 01/2022
3Biomarkers (Surrogate Marker)IBA
01/2023 - 09/2019
3salicylhydroxamic acid (SHAM)IBA
06/2022 - 12/2014
3AntigensIBA
01/2022 - 11/2013
3Long Noncoding RNAIBA
12/2021 - 09/2019
3Phosphotransferases (Kinase)IBA
01/2012 - 04/2009
3Viral ProteinsIBA
03/2010 - 09/2006
3Irinotecan (Camptosar)FDA LinkGeneric
07/2002 - 04/2002
2InflammasomesIBA
03/2024 - 07/2013
2Glucose (Dextrose)FDA LinkGeneric
03/2024 - 09/2023
2Hormones (Hormone)IBA
08/2023 - 12/2014
2Blood Glucose (Blood Sugar)IBA
01/2023 - 01/2022
2Sodium Channels (Sodium Channel)IBA
01/2022 - 01/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 09/2006
2Cisplatin (Platino)FDA LinkGeneric
12/2021 - 12/2017
2Competitive Endogenous RNAIBA
01/2021 - 09/2019
2MicroRNAs (MicroRNA)IBA
10/2020 - 01/2019
2Tyrosine Kinase InhibitorsIBA
01/2020 - 12/2015
2CarbonIBA
01/2020 - 10/2015
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
04/2017 - 08/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 11/2007
2arseniteIBA
01/2017 - 10/2014
2Mechanistic Target of Rapamycin Complex 1IBA
08/2015 - 09/2011
2CytokinesIBA
07/2013 - 04/2013
2Neoplasm Antigens (Tumor Antigens)IBA
01/2012 - 06/2010
2AntibodiesIBA
01/2012 - 09/2002
2EnzymesIBA
09/2009 - 04/2007
2sulforaphaneIBA
09/2009 - 12/2008
2OvalbuminIBA
09/2007 - 01/2004
2Docetaxel (Taxotere)FDA Link
09/2006 - 04/2004
2AllergensIBA
11/2003 - 09/2002
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
07/2002 - 07/2002
2Cyclic AMP-Dependent Protein Kinase RIalpha SubunitIBA
07/2002 - 07/2002
2Topoisomerase I InhibitorsIBA
07/2002 - 04/2002
2Antineoplastic Agents (Antineoplastics)IBA
07/2002 - 04/2002
1SincalideFDA Link
03/2024
1HMGB1 Protein (HMG1)IBA
03/2024
1Parasympatholytics (Antispasmodics)IBA
03/2024

Therapy/Procedure

19Therapeutics
02/2024 - 04/2002
5Radiotherapy
01/2021 - 02/2004
4Drug Therapy (Chemotherapy)
01/2023 - 09/2006
3Aftercare (After-Treatment)
02/2024 - 05/2018
2Hepatectomy
04/2023 - 09/2022
2Immunotherapy
01/2023 - 01/2022
2Stents
01/2019 - 08/2018
2Injections
01/2011 - 05/2009
2Cardiopulmonary Resuscitation (CPR)
04/2004 - 05/2003